The study links bacterial endotoxin LPS to amyloid diseases like T2D and AD by speeding up peptide fibrillization. CQDs counteract this by inhibiting Aβ and IAPP, indicating potential as anti-amyloidosis nanomedicine. This evidence concerns the gene IAPP and type 2 diabetes mellitus.